Randomized trials in oncology stopped early for benefit.
about
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology GThe role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014Multiple treatment comparison meta-analyses: a step forward into complexity.CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal CancersCross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trialsStopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.Emerging role of capecitabine in gastric cancer.Pharmacotherapy of triple-negative breast cancer.Breast cancer: beyond the cutting edge.Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials.Stopping clinical trials early for benefit: impact on estimation.
P2860
Q33384024-6FB2A49D-C166-4A0F-8BBD-CF4183587576Q33391312-566294F8-AA36-489C-9A8E-AB50BB1CF861Q33517961-3F131FCC-B100-463C-94F5-061D49E1CF36Q34367343-152A3B34-1EE1-4025-BFEB-52BA443C2B2FQ34402325-B82A2666-6D93-4741-8008-943B4217E018Q35089776-093866F5-39A8-4B8A-B62B-793CB7518674Q35843666-47BB4A32-84A0-4402-9EFC-4F8882840133Q36402269-0A6B167A-0799-42FE-BBA6-3D91D29A422BQ37158281-10346C4C-A766-4970-8F46-652B8DEB3580Q37403462-CD2FC9D1-D686-4778-A545-0F7DA2403F4BQ37565645-8BE0724F-42E8-4854-8CDC-1DE304DD9619Q37598890-6FC9F00B-A96D-4E93-AF16-7D7FCFB00368Q38005201-904E1F4D-CBE8-4E76-BF4F-C809C562C1C0Q43612678-EF5D8AA8-0FB4-4260-BE62-49BA2C4EE71A
P2860
Randomized trials in oncology stopped early for benefit.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Randomized trials in oncology stopped early for benefit.
@ast
Randomized trials in oncology stopped early for benefit.
@en
Randomized trials in oncology stopped early for benefit.
@nl
type
label
Randomized trials in oncology stopped early for benefit.
@ast
Randomized trials in oncology stopped early for benefit.
@en
Randomized trials in oncology stopped early for benefit.
@nl
prefLabel
Randomized trials in oncology stopped early for benefit.
@ast
Randomized trials in oncology stopped early for benefit.
@en
Randomized trials in oncology stopped early for benefit.
@nl
P50
P356
P1476
Randomized trials in oncology stopped early for benefit.
@en
P2093
H Lee Moffitt
Ryan A Wilcox
P356
10.1200/JCO.2007.13.6259
P407
P577
2008-01-01T00:00:00Z